Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Flagrante Delictu who wrote (13780)	1/26/1998 3:56:00 PM
From: Andrew H	Read Replies (1) \| Respond to of 32384

Given the fact that LGND has SO MANY COMPOUNDS in trials for SO MANY INDICATIONS with SO MANY PARTNERS, I think we can expect regular announcements of the droloxifene sort over the next few years.. Both positives and negatives. Of course this one had a silver lining--the much larger market for osteo which both Henry and I had been suggesting. However one or two positives can easily outwiegh 5 or 6 negatives and I suspect our ratio will be much better than that. Given the nature of the pipeline, the negatives are virtually meaningless for long term holders and great buying ops for traders.